Compare IOVA & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOVA | KTOS |
|---|---|---|
| Founded | 2007 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 6.3B |
| IPO Year | 2008 | 1999 |
| Metric | IOVA | KTOS |
|---|---|---|
| Price | $7.41 | $29.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 25 |
| Target Price | $14.50 | ★ $74.68 |
| AVG Volume (30 Days) | ★ 12.8M | 4.5M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.84 | ★ 18.18 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $751,900,000.00 |
| Revenue This Year | $58.86 | $33.53 |
| Revenue Next Year | $41.86 | $22.53 |
| P/E Ratio | ★ N/A | $329.39 |
| Revenue Growth | N/A | ★ 12.44 |
| 52 Week Low | $2.08 | $29.29 |
| 52 Week High | $15.37 | $134.00 |
| Indicator | IOVA | KTOS |
|---|---|---|
| Relative Strength Index (RSI) | 31.10 | 27.83 |
| Support Level | $3.57 | N/A |
| Resistance Level | $9.36 | $50.59 |
| Average True Range (ATR) | 0.57 | 2.36 |
| MACD | -0.13 | -0.61 |
| Stochastic Oscillator | 4.34 | 0.09 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.